Results 191 to 200 of about 582,427 (291)
Motor Competence in Greek Adolescents Using Movement Assessment Battery for Children-2nd Edition: Associations with Individual and Environmental Factors. [PDF]
Katartzi E, Kontou M.
europepmc +1 more source
ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang +3 more
wiley +1 more source
A case of subserosal bile infiltration due to gallbladder injury during robot-assisted nephrectomy (with video). [PDF]
Minezaki S +14 more
europepmc +1 more source
ABSTRACT Background In patients with acute coronary syndrome (ACS) and multivessel disease (MVD), complete revascularization (CR) improves clinical outcomes compared with culprit‐only percutaneous coronary intervention (PCI). However, the optimal timing of CR, immediate (ICR) versus staged (SCR), remains debated.
Alessandro Gabrielli +7 more
wiley +1 more source
Postgraduate Education in Renaissance: A Definite Requisite
Mugdha P. Mankar
doaj +1 more source
Immune-inflammatory prediction of PICC-related bloodstream infection in oldest-old adults with exploratory berberine biofilm-inflammation experiments. [PDF]
Li X, Chen F, Zheng C, Yin S.
europepmc +1 more source
ABSTRACT Background In the REFORM trial, treatment of coronary in‐stent restenosis with a Biolimus A9™ drug‐coated balloon (BCB) was found to be inferior with respect to in‐segment percentage stenosis at 6‐months in comparison to treatment with a standard paclitaxel coated paclitaxel‐coated balloon (PCB). Aims In this manuscript, the final prespecified
Daniel O'Callaghan +18 more
wiley +1 more source
Nonnegative definite hermitian matrices with increasing principal minors
Friedland Shmuel
doaj +1 more source
Prevalence and clinical correlates of autoimmune and infection-related antibodies in unexplained seizures in western China. [PDF]
Yuan Y, Su Y, Wang M, He Y.
europepmc +1 more source
ABSTRACT Background Biodegradable‐polymer (BP) drug‐eluting stents (DES) were developed to mitigate potential late adverse events related to persistent durable polymers in durable‐polymer (DP) DES; however, contemporary long‐term real‐world comparative data remain limited. Aims We aimed to compare the 5‐year clinical outcomes of contemporary BP‐DES and
Yangyoun Lee +6 more
wiley +1 more source

